Allergy, Hypersensitivity and Asthma

ALLERGY: Allergy is developing in prevalence and pharmacotherapy alone cannot control the disease.Allergy Immunotherapy   activate immunological tolerance and changes the course of disease.

HYPERSENSTIVITY: All cancer chemotherapeutic agents, exclude altretamine, the nitrosoureas, and dactinomycin, have composed at least an isolated instance of a HSR. convinced drugs, such as L-asparaginase and mitomycin (administered intravesically), cause HSRs of significant degree in approximately 10% of patients.

ASTHMA: Asthma is a natural disease that influence 300 million people worldwide. Given the large number of   eosinophils   in the airways of people with mild asthma, and documented by data from murine models, asthma was long treated the hallmark T helper type 2 (TH2) disease of the airways.

    Related Conference of Allergy, Hypersensitivity and Asthma

    November 08-09, 2021

    International Conference on Immunology Research

    Las Vegas, USA
    December 17-18, 2021

    11th International Conference on Bacteriology and Infectious Diseases

    Cape Town, South Africa
    December 20-21, 2021

    9th World Summit on Immunology & Immunotherapy

    Prague, Czech Republic
    December 23-23, 2021

    13th Annual Conference on Clinical Immunology

    Cape Town, South Africa
    December 23-23, 2021

    3rd International Conference on Viral Infection and Immune Response

    Amsterdam, Netherlands
    February 07-08, 2022

    International Conference on Vaccine Research

    Paris, France
    March 21-22, 2022

    37th International Conference on Immunology

    Brussels, Aland Islands
    March 21-22, 2022

    15th Global Summit on Immunology and Cell Biology

    Tokyo, Japan
    May 02-03, 2022

    16th International Conference on European Immunology

    Zurich, Switzerland

    Allergy, Hypersensitivity and Asthma Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in